Press releasePRNewswire
MiniMed Group
MMED · NASDAQ
$17.49−$0.30 (−1.69%)TodayMarket closed ·
Prev close $17.79
Latest news
- Press releasePRNewswire
Medtronic Completes Separation of MiniMed Group, Inc.
- Press releasePRNewswire
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
- NewsErica Kollmann
Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse
- Press releasePRNewswire
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
- NewsAvi Kapoor
Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus
- Press releasePRNewswire
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
- Press releasePRNewswire
Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes
- Press releasePRNewswire
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
- NewsErica Kollmann
Squeeze Watch: 10 Stocks With Over 33% Short Interest
- Press releasePRNewswire
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
- Press releasePRNewswire
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
- NewsAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
- NewsAvi Kapoor
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
Minimed Group Q1 2027 Earnings Call Transcript
- NewsAvi Kapoor
Yext Posts Upbeat Q2 Earnings, Joins Fervo Energy, MiniMed Group And Other Big Stocks Moving Higher On Tuesday
- Press releasePRNewswire
MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
- NewsAvi Kapoor
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
- NewsVandana Singh
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
- Press releasePRNewswire
MiniMed to Participate in Upcoming Investor Conferences
- Press releasePRNewswire
MiniMed's Smallest App-Controlled Insulin Pump Now Shipping with the World's Smallest Sensor
- Press releasePRNewswire
MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries
- Press releasePRNewswire
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results
- Press releasePRNewswire
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
- Press releasePRNewswire
MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes
- Press releasePRNewswire
MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
Full Transcript: Minimed Group Q4 2026 Earnings Call
- News
MiniMed Announces Expanded Agreement With Abbott To Collaborate On Commercializing Dual Glucose-Ketone Sensors Designed To Integrate Exclusively With MiniMed Smart Dosing Systems
- Press releasePRNewswire
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
- Press releasePRNewswire
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook
- Press releasePRNewswire
MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions
- Press releasePRNewswire
MiniMed to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
- Press releasePRNewswire
New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System
- News
Goldman Sachs' 2 Favorite Under-the-Radar Stocks
- Press releasePRNewswire
MiniMed to announce financial results for its fourth quarter and full fiscal year 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.